Global Cancer Gene Therapy Market Research Report 2026(Status and Outlook)
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Cancer Gene Therapy market size was estimated at USD 719.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Gene Therapy market.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Gene Therapy Market
Overview of the regional outlook of the Cancer Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cancer Gene Therapy market size was estimated at USD 719.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Gene Therapy market.
Global Cancer Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Market Segmentation (by Type)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Market Segmentation (by Application)
Hospitals
Diagnostics Centers
Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cancer Gene Therapy Market
Overview of the regional outlook of the Cancer Gene Therapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Gene Therapy Product Life Cycle
3.3 Global Cancer Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Gene Therapy Market Competitive Situation and Trends
3.8.1 Cancer Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 CANCER GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Cancer Gene Therapy Market Size by Type (2020-2025)
6.4 Global Cancer Gene Therapy Price by Type (2020-2025)
7 CANCER GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
8 CANCER GENE THERAPY MARKET SALES BY REGION
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 Global Cancer Gene Therapy Market Size by Region
8.2.1 Global Cancer Gene Therapy Market Size by Region
8.2.2 Global Cancer Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Cancer Gene Therapy Sales by Country
8.3.2 North America Cancer Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Gene Therapy Sales by Country
8.4.2 Europe Cancer Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.5.2 Asia Pacific Cancer Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Gene Therapy Sales by Country
8.6.2 South America Cancer Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.7.2 Middle East and Africa Cancer Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Gene Therapy by Region(2020-2025)
9.2 Global Cancer Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Gene Therapy Production
9.4.1 North America Cancer Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Gene Therapy Production
9.5.1 Europe Cancer Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Gene Therapy Production (2020-2025)
9.6.1 Japan Cancer Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Gene Therapy Production (2020-2025)
9.7.1 China Cancer Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adaptimmune
10.1.1 Adaptimmune Basic Information
10.1.2 Adaptimmune Cancer Gene Therapy Product Overview
10.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
10.1.4 Adaptimmune Business Overview
10.1.5 Adaptimmune SWOT Analysis
10.1.6 Adaptimmune Recent Developments
10.2 Bluebird bio
10.2.1 Bluebird bio Basic Information
10.2.2 Bluebird bio Cancer Gene Therapy Product Overview
10.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
10.2.4 Bluebird bio Business Overview
10.2.5 Bluebird bio SWOT Analysis
10.2.6 Bluebird bio Recent Developments
10.3 Celgene
10.3.1 Celgene Basic Information
10.3.2 Celgene Cancer Gene Therapy Product Overview
10.3.3 Celgene Cancer Gene Therapy Product Market Performance
10.3.4 Celgene Business Overview
10.3.5 Celgene SWOT Analysis
10.3.6 Celgene Recent Developments
10.4 Shanghai Sunway Biotech
10.4.1 Shanghai Sunway Biotech Basic Information
10.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
10.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
10.4.4 Shanghai Sunway Biotech Business Overview
10.4.5 Shanghai Sunway Biotech Recent Developments
10.5 Shenzhen SiBiono GeneTech
10.5.1 Shenzhen SiBiono GeneTech Basic Information
10.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
10.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
10.5.4 Shenzhen SiBiono GeneTech Business Overview
10.5.5 Shenzhen SiBiono GeneTech Recent Developments
10.6 SynerGene Therapeutics
10.6.1 SynerGene Therapeutics Basic Information
10.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
10.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
10.6.4 SynerGene Therapeutics Business Overview
10.6.5 SynerGene Therapeutics Recent Developments
10.7 Altor BioScience
10.7.1 Altor BioScience Basic Information
10.7.2 Altor BioScience Cancer Gene Therapy Product Overview
10.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
10.7.4 Altor BioScience Business Overview
10.7.5 Altor BioScience Recent Developments
10.8 Amgen
10.8.1 Amgen Basic Information
10.8.2 Amgen Cancer Gene Therapy Product Overview
10.8.3 Amgen Cancer Gene Therapy Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 Argenx
10.9.1 Argenx Basic Information
10.9.2 Argenx Cancer Gene Therapy Product Overview
10.9.3 Argenx Cancer Gene Therapy Product Market Performance
10.9.4 Argenx Business Overview
10.9.5 Argenx Recent Developments
10.10 BioCancell
10.10.1 BioCancell Basic Information
10.10.2 BioCancell Cancer Gene Therapy Product Overview
10.10.3 BioCancell Cancer Gene Therapy Product Market Performance
10.10.4 BioCancell Business Overview
10.10.5 BioCancell Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Basic Information
10.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
10.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 Merck
10.12.1 Merck Basic Information
10.12.2 Merck Cancer Gene Therapy Product Overview
10.12.3 Merck Cancer Gene Therapy Product Market Performance
10.12.4 Merck Business Overview
10.12.5 Merck Recent Developments
10.13 OncoGenex Pharmaceuticals
10.13.1 OncoGenex Pharmaceuticals Basic Information
10.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
10.13.4 OncoGenex Pharmaceuticals Business Overview
10.13.5 OncoGenex Pharmaceuticals Recent Developments
10.14 Transgene
10.14.1 Transgene Basic Information
10.14.2 Transgene Cancer Gene Therapy Product Overview
10.14.3 Transgene Cancer Gene Therapy Product Market Performance
10.14.4 Transgene Business Overview
10.14.5 Transgene Recent Developments
11 CANCER GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Cancer Gene Therapy Market Size Forecast
11.2 Global Cancer Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
11.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cancer Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2026-2035)
12.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2026-2035)
12.2 Global Cancer Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Gene Therapy
1.2 Key Market Segments
1.2.1 Cancer Gene Therapy Segment by Type
1.2.2 Cancer Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cancer Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Cancer Gene Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Gene Therapy Product Life Cycle
3.3 Global Cancer Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Cancer Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cancer Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cancer Gene Therapy Market Competitive Situation and Trends
3.8.1 Cancer Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cancer Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANCER GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Cancer Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cancer Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 CANCER GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Cancer Gene Therapy Market Size by Type (2020-2025)
6.4 Global Cancer Gene Therapy Price by Type (2020-2025)
7 CANCER GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Cancer Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
8 CANCER GENE THERAPY MARKET SALES BY REGION
8.1 Global Cancer Gene Therapy Sales by Region
8.1.1 Global Cancer Gene Therapy Sales by Region
8.1.2 Global Cancer Gene Therapy Sales Market Share by Region
8.2 Global Cancer Gene Therapy Market Size by Region
8.2.1 Global Cancer Gene Therapy Market Size by Region
8.2.2 Global Cancer Gene Therapy Market Size by Region
8.3 North America
8.3.1 North America Cancer Gene Therapy Sales by Country
8.3.2 North America Cancer Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cancer Gene Therapy Sales by Country
8.4.2 Europe Cancer Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cancer Gene Therapy Sales by Region
8.5.2 Asia Pacific Cancer Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cancer Gene Therapy Sales by Country
8.6.2 South America Cancer Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cancer Gene Therapy Sales by Region
8.7.2 Middle East and Africa Cancer Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANCER GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Cancer Gene Therapy by Region(2020-2025)
9.2 Global Cancer Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cancer Gene Therapy Production
9.4.1 North America Cancer Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cancer Gene Therapy Production
9.5.1 Europe Cancer Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cancer Gene Therapy Production (2020-2025)
9.6.1 Japan Cancer Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cancer Gene Therapy Production (2020-2025)
9.7.1 China Cancer Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Cancer Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Adaptimmune
10.1.1 Adaptimmune Basic Information
10.1.2 Adaptimmune Cancer Gene Therapy Product Overview
10.1.3 Adaptimmune Cancer Gene Therapy Product Market Performance
10.1.4 Adaptimmune Business Overview
10.1.5 Adaptimmune SWOT Analysis
10.1.6 Adaptimmune Recent Developments
10.2 Bluebird bio
10.2.1 Bluebird bio Basic Information
10.2.2 Bluebird bio Cancer Gene Therapy Product Overview
10.2.3 Bluebird bio Cancer Gene Therapy Product Market Performance
10.2.4 Bluebird bio Business Overview
10.2.5 Bluebird bio SWOT Analysis
10.2.6 Bluebird bio Recent Developments
10.3 Celgene
10.3.1 Celgene Basic Information
10.3.2 Celgene Cancer Gene Therapy Product Overview
10.3.3 Celgene Cancer Gene Therapy Product Market Performance
10.3.4 Celgene Business Overview
10.3.5 Celgene SWOT Analysis
10.3.6 Celgene Recent Developments
10.4 Shanghai Sunway Biotech
10.4.1 Shanghai Sunway Biotech Basic Information
10.4.2 Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
10.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Product Market Performance
10.4.4 Shanghai Sunway Biotech Business Overview
10.4.5 Shanghai Sunway Biotech Recent Developments
10.5 Shenzhen SiBiono GeneTech
10.5.1 Shenzhen SiBiono GeneTech Basic Information
10.5.2 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
10.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Market Performance
10.5.4 Shenzhen SiBiono GeneTech Business Overview
10.5.5 Shenzhen SiBiono GeneTech Recent Developments
10.6 SynerGene Therapeutics
10.6.1 SynerGene Therapeutics Basic Information
10.6.2 SynerGene Therapeutics Cancer Gene Therapy Product Overview
10.6.3 SynerGene Therapeutics Cancer Gene Therapy Product Market Performance
10.6.4 SynerGene Therapeutics Business Overview
10.6.5 SynerGene Therapeutics Recent Developments
10.7 Altor BioScience
10.7.1 Altor BioScience Basic Information
10.7.2 Altor BioScience Cancer Gene Therapy Product Overview
10.7.3 Altor BioScience Cancer Gene Therapy Product Market Performance
10.7.4 Altor BioScience Business Overview
10.7.5 Altor BioScience Recent Developments
10.8 Amgen
10.8.1 Amgen Basic Information
10.8.2 Amgen Cancer Gene Therapy Product Overview
10.8.3 Amgen Cancer Gene Therapy Product Market Performance
10.8.4 Amgen Business Overview
10.8.5 Amgen Recent Developments
10.9 Argenx
10.9.1 Argenx Basic Information
10.9.2 Argenx Cancer Gene Therapy Product Overview
10.9.3 Argenx Cancer Gene Therapy Product Market Performance
10.9.4 Argenx Business Overview
10.9.5 Argenx Recent Developments
10.10 BioCancell
10.10.1 BioCancell Basic Information
10.10.2 BioCancell Cancer Gene Therapy Product Overview
10.10.3 BioCancell Cancer Gene Therapy Product Market Performance
10.10.4 BioCancell Business Overview
10.10.5 BioCancell Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Basic Information
10.11.2 GlaxoSmithKline Cancer Gene Therapy Product Overview
10.11.3 GlaxoSmithKline Cancer Gene Therapy Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 Merck
10.12.1 Merck Basic Information
10.12.2 Merck Cancer Gene Therapy Product Overview
10.12.3 Merck Cancer Gene Therapy Product Market Performance
10.12.4 Merck Business Overview
10.12.5 Merck Recent Developments
10.13 OncoGenex Pharmaceuticals
10.13.1 OncoGenex Pharmaceuticals Basic Information
10.13.2 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
10.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Product Market Performance
10.13.4 OncoGenex Pharmaceuticals Business Overview
10.13.5 OncoGenex Pharmaceuticals Recent Developments
10.14 Transgene
10.14.1 Transgene Basic Information
10.14.2 Transgene Cancer Gene Therapy Product Overview
10.14.3 Transgene Cancer Gene Therapy Product Market Performance
10.14.4 Transgene Business Overview
10.14.5 Transgene Recent Developments
11 CANCER GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Cancer Gene Therapy Market Size Forecast
11.2 Global Cancer Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cancer Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Cancer Gene Therapy Market Size Forecast by Region
11.2.4 South America Cancer Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cancer Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Cancer Gene Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Cancer Gene Therapy by Type (2026-2035)
12.1.2 Global Cancer Gene Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Cancer Gene Therapy by Type (2026-2035)
12.2 Global Cancer Gene Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Cancer Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Cancer Gene Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 4. Global Cancer Gene Therapy Market Size by Application
Table 5. Cancer Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Cancer Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cancer Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cancer Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cancer Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2025)
Table 11. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cancer Gene Therapy Sales by Type (K Units)
Table 27. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 28. Global Cancer Gene Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Cancer Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Cancer Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Cancer Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Cancer Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cancer Gene Therapy Sales (K Units) by Application
Table 34. Global Cancer Gene Therapy Market Size by Application
Table 35. Global Cancer Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Cancer Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Cancer Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cancer Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Cancer Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cancer Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cancer Gene Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Cancer Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cancer Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adaptimmune Basic Information
Table 63. Adaptimmune Cancer Gene Therapy Product Overview
Table 64. Adaptimmune Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune SWOT Analysis
Table 67. Adaptimmune Recent Developments
Table 68. Bluebird bio Basic Information
Table 69. Bluebird bio Cancer Gene Therapy Product Overview
Table 70. Bluebird bio Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bluebird bio Business Overview
Table 72. Bluebird bio SWOT Analysis
Table 73. Bluebird bio Recent Developments
Table 74. Celgene Basic Information
Table 75. Celgene Cancer Gene Therapy Product Overview
Table 76. Celgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Celgene Business Overview
Table 78. Celgene SWOT Analysis
Table 79. Celgene Recent Developments
Table 80. Shanghai Sunway Biotech Basic Information
Table 81. Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
Table 82. Shanghai Sunway Biotech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Shanghai Sunway Biotech Business Overview
Table 84. Shanghai Sunway Biotech Recent Developments
Table 85. Shenzhen SiBiono GeneTech Basic Information
Table 86. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
Table 87. Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Shenzhen SiBiono GeneTech Business Overview
Table 89. Shenzhen SiBiono GeneTech Recent Developments
Table 90. SynerGene Therapeutics Basic Information
Table 91. SynerGene Therapeutics Cancer Gene Therapy Product Overview
Table 92. SynerGene Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. SynerGene Therapeutics Business Overview
Table 94. SynerGene Therapeutics Recent Developments
Table 95. Altor BioScience Basic Information
Table 96. Altor BioScience Cancer Gene Therapy Product Overview
Table 97. Altor BioScience Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Altor BioScience Business Overview
Table 99. Altor BioScience Recent Developments
Table 100. Amgen Basic Information
Table 101. Amgen Cancer Gene Therapy Product Overview
Table 102. Amgen Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Amgen Business Overview
Table 104. Amgen Recent Developments
Table 105. Argenx Basic Information
Table 106. Argenx Cancer Gene Therapy Product Overview
Table 107. Argenx Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Argenx Business Overview
Table 109. Argenx Recent Developments
Table 110. BioCancell Basic Information
Table 111. BioCancell Cancer Gene Therapy Product Overview
Table 112. BioCancell Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BioCancell Business Overview
Table 114. BioCancell Recent Developments
Table 115. GlaxoSmithKline Basic Information
Table 116. GlaxoSmithKline Cancer Gene Therapy Product Overview
Table 117. GlaxoSmithKline Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Recent Developments
Table 120. Merck Basic Information
Table 121. Merck Cancer Gene Therapy Product Overview
Table 122. Merck Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Merck Business Overview
Table 124. Merck Recent Developments
Table 125. OncoGenex Pharmaceuticals Basic Information
Table 126. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
Table 127. OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. OncoGenex Pharmaceuticals Business Overview
Table 129. OncoGenex Pharmaceuticals Recent Developments
Table 130. Transgene Basic Information
Table 131. Transgene Cancer Gene Therapy Product Overview
Table 132. Transgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Transgene Business Overview
Table 134. Transgene Recent Developments
Table 135. Global Cancer Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Cancer Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Cancer Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Cancer Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Cancer Gene Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Cancer Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Cancer Gene Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Cancer Gene Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Cancer Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 4. Global Cancer Gene Therapy Market Size by Application
Table 5. Cancer Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Cancer Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Cancer Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Cancer Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Cancer Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2025)
Table 11. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Cancer Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Cancer Gene Therapy Sales by Type (K Units)
Table 27. Global Cancer Gene Therapy Market Size by Type (M USD)
Table 28. Global Cancer Gene Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Cancer Gene Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Cancer Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Cancer Gene Therapy Market Share by Type (2020-2025)
Table 32. Global Cancer Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Cancer Gene Therapy Sales (K Units) by Application
Table 34. Global Cancer Gene Therapy Market Size by Application
Table 35. Global Cancer Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Cancer Gene Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Cancer Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Cancer Gene Therapy Market Share by Application (2020-2025)
Table 39. Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Cancer Gene Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Cancer Gene Therapy Market Size by Region (2020-2025)
Table 44. North America Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Cancer Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Cancer Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Cancer Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Cancer Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Cancer Gene Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Cancer Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Cancer Gene Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Cancer Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Adaptimmune Basic Information
Table 63. Adaptimmune Cancer Gene Therapy Product Overview
Table 64. Adaptimmune Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune SWOT Analysis
Table 67. Adaptimmune Recent Developments
Table 68. Bluebird bio Basic Information
Table 69. Bluebird bio Cancer Gene Therapy Product Overview
Table 70. Bluebird bio Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bluebird bio Business Overview
Table 72. Bluebird bio SWOT Analysis
Table 73. Bluebird bio Recent Developments
Table 74. Celgene Basic Information
Table 75. Celgene Cancer Gene Therapy Product Overview
Table 76. Celgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Celgene Business Overview
Table 78. Celgene SWOT Analysis
Table 79. Celgene Recent Developments
Table 80. Shanghai Sunway Biotech Basic Information
Table 81. Shanghai Sunway Biotech Cancer Gene Therapy Product Overview
Table 82. Shanghai Sunway Biotech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Shanghai Sunway Biotech Business Overview
Table 84. Shanghai Sunway Biotech Recent Developments
Table 85. Shenzhen SiBiono GeneTech Basic Information
Table 86. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product Overview
Table 87. Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Shenzhen SiBiono GeneTech Business Overview
Table 89. Shenzhen SiBiono GeneTech Recent Developments
Table 90. SynerGene Therapeutics Basic Information
Table 91. SynerGene Therapeutics Cancer Gene Therapy Product Overview
Table 92. SynerGene Therapeutics Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. SynerGene Therapeutics Business Overview
Table 94. SynerGene Therapeutics Recent Developments
Table 95. Altor BioScience Basic Information
Table 96. Altor BioScience Cancer Gene Therapy Product Overview
Table 97. Altor BioScience Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Altor BioScience Business Overview
Table 99. Altor BioScience Recent Developments
Table 100. Amgen Basic Information
Table 101. Amgen Cancer Gene Therapy Product Overview
Table 102. Amgen Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Amgen Business Overview
Table 104. Amgen Recent Developments
Table 105. Argenx Basic Information
Table 106. Argenx Cancer Gene Therapy Product Overview
Table 107. Argenx Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Argenx Business Overview
Table 109. Argenx Recent Developments
Table 110. BioCancell Basic Information
Table 111. BioCancell Cancer Gene Therapy Product Overview
Table 112. BioCancell Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BioCancell Business Overview
Table 114. BioCancell Recent Developments
Table 115. GlaxoSmithKline Basic Information
Table 116. GlaxoSmithKline Cancer Gene Therapy Product Overview
Table 117. GlaxoSmithKline Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Recent Developments
Table 120. Merck Basic Information
Table 121. Merck Cancer Gene Therapy Product Overview
Table 122. Merck Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Merck Business Overview
Table 124. Merck Recent Developments
Table 125. OncoGenex Pharmaceuticals Basic Information
Table 126. OncoGenex Pharmaceuticals Cancer Gene Therapy Product Overview
Table 127. OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. OncoGenex Pharmaceuticals Business Overview
Table 129. OncoGenex Pharmaceuticals Recent Developments
Table 130. Transgene Basic Information
Table 131. Transgene Cancer Gene Therapy Product Overview
Table 132. Transgene Cancer Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Transgene Business Overview
Table 134. Transgene Recent Developments
Table 135. Global Cancer Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Cancer Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Cancer Gene Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Cancer Gene Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Cancer Gene Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Cancer Gene Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Cancer Gene Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Cancer Gene Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Cancer Gene Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Cancer Gene Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Cancer Gene Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Cancer Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Cancer Gene Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Gene Therapy Product Life Cycle
Figure 13. Cancer Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Cancer Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Cancer Gene Therapy
Figure 19. Global Cancer Gene Therapy Market PEST Analysis
Figure 20. Global Cancer Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Cancer Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Gene Therapy by Type in 2025
Figure 29. Market Share of Cancer Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Cancer Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Gene Therapy Market Share by Application
Figure 33. Global Cancer Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Cancer Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Cancer Gene Therapy Market Share by Application in 2025
Figure 37. Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Gene Therapy Market Size by Country in 2024
Figure 55. Germany Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Gene Therapy Market Size by Region in 2024
Figure 68. China Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Cancer Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Gene Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cancer Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cancer Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cancer Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Cancer Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Cancer Gene Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Cancer Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Gene Therapy Market Size (M USD), 2025-2035
Figure 5. Global Cancer Gene Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Cancer Gene Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cancer Gene Therapy Product Life Cycle
Figure 13. Cancer Gene Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Cancer Gene Therapy Revenue Share by Manufacturers in 2025
Figure 15. Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Cancer Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cancer Gene Therapy Revenue in 2025
Figure 18. Industry Chain Map of Cancer Gene Therapy
Figure 19. Global Cancer Gene Therapy Market PEST Analysis
Figure 20. Global Cancer Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cancer Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Cancer Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Cancer Gene Therapy by Type in 2025
Figure 29. Market Share of Cancer Gene Therapy by Type (2020-2025)
Figure 30. Market Share of Cancer Gene Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cancer Gene Therapy Market Share by Application
Figure 33. Global Cancer Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Cancer Gene Therapy Sales Market Share by Application in 2025
Figure 35. Global Cancer Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Cancer Gene Therapy Market Share by Application in 2025
Figure 37. Global Cancer Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cancer Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Cancer Gene Therapy Market Size by Region (2020-2025)
Figure 40. North America Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cancer Gene Therapy Market Size by Country in 2024
Figure 45. U.S. Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cancer Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cancer Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cancer Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cancer Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cancer Gene Therapy Market Size by Country in 2024
Figure 55. Germany Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cancer Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cancer Gene Therapy Market Size by Region in 2024
Figure 68. China Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Cancer Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Cancer Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Cancer Gene Therapy Market Size by Country in 2024
Figure 82. Brazil Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cancer Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cancer Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cancer Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cancer Gene Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cancer Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cancer Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cancer Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cancer Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cancer Gene Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Cancer Gene Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Cancer Gene Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Cancer Gene Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Cancer Gene Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Cancer Gene Therapy Market Share Forecast by Application (2026-2035)
